Ideal cardiovascular health during adult life and cardiovascular structure and function among the elderly

Circulation

Volumn 132, Issue 21, 2015, Pages 1979-1989

  Shah, Amil M ^a   Claggett, Brian ^a   Folsom, Aaron R ^b   Lutsey, Pamela L ^b   Ballantyne, Christie M ^c   Heiss, Gerardo ^d   Solomon, Scott D ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d IL   (United States)

Author keywords

aging; cardiovascular diseases; echocardiography; epidemiology; risk factors

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; CHOLESTEROL; GLUCOSE; TROPONIN T; GLUCOSE BLOOD LEVEL;

ADULT; AGE; AGED; AORTA ROOT; ARTERIAL STIFFNESS; ARTICLE; ATRIAL FIBRILLATION; BLACK PERSON; BODY MASS; CARDIOVASCULAR FUNCTION; CAUCASIAN; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; COMORBIDITY; FEMALE; FOLLOW UP; GERIATRIC PATIENT; GLUCOSE BLOOD LEVEL; HEALTH BEHAVIOR; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE SIZE; HEART VENTRICLE WALL; HUMAN; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PULSE WAVE; RACE DIFFERENCE; SMOKING; AGING; ANALYSIS; CARDIOVASCULAR DISEASES; DIAGNOSTIC IMAGING; ECHOGRAPHY; HEALTH STATUS INDICATOR; HEART; HYPERGLYCEMIA; HYPERTENSION; MEDICAL SOCIETY; MIDDLE AGED; MOTOR ACTIVITY; OVERWEIGHT; PATHOPHYSIOLOGY; PHYSIOLOGY; PREVALENCE; PROSPECTIVE STUDY; RISK FACTOR; UNITED STATES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AGING; AMERICAN HEART ASSOCIATION; BLOOD GLUCOSE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; HEALTH STATUS INDICATORS; HEART; HUMANS; HYPERGLYCEMIA; HYPERTENSION; MIDDLE AGED; MOTOR ACTIVITY; OVERWEIGHT; PREVALENCE; PROSPECTIVE STUDIES; PULSE WAVE ANALYSIS; RISK FACTORS; SMOKING; ULTRASONOGRAPHY; UNITED STATES;

EID: 84948096748     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.115.017882     Document Type: Article

References (34)

1. Lloyd-Jones DM, Hong Y, Labarthe D, Mozaffarian D, Appel LJ, Van Horn L, Greenlund K, Daniels S, Nichol G, Tomaselli GF, Arnett DK, Fonarow GC, Ho PM, Lauer MS, Masoudi FA, Robertson RM, Roger V, Schwamm LH, Sorlie P, Yancy CW, Rosamond WD. American Heart Association Strategic Planning Task Force and Statistics Committee. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond. Circulation. 2010; 121: 586-613. doi: 10.1161/CIRCULATIONAHA.109.192703.
2. Folsom AR, Yatsuya H, Nettleton JA, Lutsey PL, Cushman M, Rosamond WD. ARIC Study Investigators. Community prevalence of ideal cardiovascular health, by the American Heart Association definition, and relationship with cardiovascular disease incidence. J Am Coll Cardiol. 2011; 57: 1690-1696. doi: 10.1016/j.jacc.2010.11.041.
3. American Heart Association. Heart Disease and Stroke Statistics - 2009 Update. Dallas, TX: American Heart Association; 2009.
4. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW. American College of Cardiology Foundation; American Heart Association. 2009 Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation. J Am Coll Cardiol. 2009; 53: e1-e90. doi: 10.1016/j.jacc.2008.11.013.
5. Folsom AR, Yamagishi K, Hozawa A, Chambless LE. Atherosclerosis Risk in Communities Study Investigators. Absolute and attributable risks of heart failure incidence in relation to optimal risk factors. Circ Heart Fail. 2009; 2: 11-17. doi: 10.1161/CIRCHEARTFAILURE.108.794933.
6. The ARIC Investigators. The Atherosclerosis Risk in Communities (ARIC) study: design and objectives. Am J Epidemiol. 1989; 129: 687-702.
7. White A, Folsom A, Chambless L, Sharret AR, Yang K, Conwill D, Higgins M, Williams OD, Tyroler HA. Community surveillance of coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) Study: methods and initial two years' experience. J Clin Epidemiol. 1996; 49: 223-233.
8. Loehr LR, Rosamond WD, Chang PP, Folsom AR, Chambless LE. Heart failure incidence and survival (from the Atherosclerosis Risk in Communities study). Am J Cardiol. 2008; 101: 1016-1022. doi: 10.1016/j. amjcard.2007.11.061.
9. Rosamond WD, Chang PP, Baggett C, Johnson A, Bertoni AG, Shahar E, Deswal A, Heiss G, Chambless LE. Classification of heart failure in the atherosclerosis risk in communities (ARIC) study: a comparison of diagnostic criteria. Circ Heart Fail. 2012; 5: 152-159. doi: 10.1161/.CIRCHEARTFAILURE.111.963199.
10. Alonso A, Agarwal SK, Soliman EZ, Ambrose M, Chamberlain AM, Prineas RJ, Folsom AR. Incidence of atrial fibrillation in whites and African-Americans: the Atherosclerosis Risk in Communities (ARIC) study. Am Heart J. 2009; 158: 111-117. doi: 10.1016/j.ahj.2009.05.010.
11. Shah AM, Cheng S, Skali H, Wu J, Mangion JR, Kitzman D, Matsushita K, Konety S, Butler KR, Fox ER, Cook N, Ni H, Coresh J, Mosley TH, Heiss G, Folsom AR, Solomon SD. Rationale and design of a multicenter echocardiographic study to assess the relationship between cardiac structure and function and heart failure risk in a biracial cohort of community-dwelling elderly persons: the Atherosclerosis Risk in Communities study. Circ Cardiovasc Imaging. 2014; 7: 173-181. doi: 10.1161/.CIRCIMAGING.113.000736.
12. Cortez-Cooper MY, Supak JA, Tanaka H A new device for automatic measurements of arterial stiffness and ankle-brachial index. Am J Cardiol. 2003; 91: 1519-22, A9.
13. Allen NB, Siddique J, Wilkins JT, Shay C, Lewis CE, Goff DC, Jacobs DR Jr, Liu K, Lloyd-Jones D. Blood pressure trajectories in early adulthood and subclinical atherosclerosis in middle age. JAMA. 2014; 311: 490-497. doi: 10.1001/jama.2013.285122.
14. Gill TM, Murphy TE, Gahbauer EA, Allore HG. The course of disability before and after a serious fall injury. JAMA Intern Med. 2013; 173: 1780-1786. doi: 10.1001/jamainternmed.2013.9063.
15. Weuve J, Tchetgen Tchetgen EJ, Glymour MM, Beck TL, Aggarwal NT, Wilson RS, Evans DA, Mendes de Leon CF. Accounting for bias due to selective attrition: the example of smoking and cognitive decline. Epidemiology. 2012; 23: 119-128. doi: 10.1097/EDE.0b013e318230e861.
16. Gottesman RF, Rawlings AM, Sharrett AR, Albert M, Alonso A, Bandeen-Roche K, Coker LH, Coresh J, Couper DJ, Griswold ME, Heiss G, Knopman DS, Patel MD, Penman AD, Power MC, Selnes OA, Schneider AL, Wagenknecht LE, Windham BG, Wruck LM, Mosley TH. Impact of differential attrition on the association of education with cognitive change over 20 years of follow-up: the ARIC neurocognitive study. Am J Epidemiol. 2014; 179: 956-966. doi: 10.1093/aje/kwu020.
17. Berry JD, Dyer A, Cai X, Garside DB, Ning H, Thomas A, Greenland P, Van Horn L, Tracy RP, Lloyd-Jones DM. Lifetime risks of cardiovascular disease. N Engl J Med. 2012; 366: 321-329. doi: 10.1056/.NEJMoa1012848.
18. Yang Q, Cogswell ME, Flanders WD, Hong Y, Zhang Z, Loustalot F, Gillespie C, Merritt R, Hu FB. Trends in cardiovascular health metrics and associations with all-cause and CVD mortality among US adults. JAMA. 2012; 307: 1273-1283. doi: 10.1001/jama.2012.339.
19. Bambs C, Kip KE, Dinga A, Mulukutla SR, Aiyer AN, Reis SE. Low prevalence of "ideal cardiovascular health" in a communitybased population: the heart strategies concentrating on risk evaluation (Heart SCORE) study. Circulation. 2011; 123: 850-857. doi: 10.1161/.CIRCULATIONAHA.110.980151.
20. Shay CM, Ning H, Allen NB, Carnethon MR, Chiuve SE, Greenlund KJ, Daviglus ML, Lloyd-Jones DM. Status of cardiovascular health in US adults: prevalence estimates from the National Health and Nutrition Examination Surveys (NHANES) 2003-2008. Circulation. 2012; 125: 45-56. doi: 10.1161/CIRCULATIONAHA.111.035733.
21. Dong C, Rundek T, Wright CB, Anwar Z, Elkind MS, Sacco RL. Ideal cardiovascular health predicts lower risks of myocardial infarction, stroke, and vascular death across whites, blacks, and Hispanics: the northern Manhattan study. Circulation. 2012; 125: 2975-2984. doi: 10.1161/.CIRCULATIONAHA.111.081083.
22. Wu S, Huang Z, Yang X, Zhou Y, Wang A, Chen L, Zhao H, Ruan C, Wu Y, Xin A, Li K, Jin C, Cai J. Prevalence of ideal cardiovascular health and its relationship with the 4-year cardiovascular events in a northern Chinese industrial city. Circ Cardiovasc Qual Outcomes. 2012; 5: 487-493. doi: 10.1161/CIRCOUTCOMES.111.963694.
23. Ogagarue ER, Lutsey PL, Klein R, Klein BE, Folsom AR. Association of ideal cardiovascular health metrics and retinal microvascular findings: the Atherosclerosis Risk in Communities Study. J Am Heart Assoc. 2013; 2: e000430. doi: 10.1161/JAHA.113.000430.
24. Xanthakis V, Enserro DM, Murabito JM, Polak JF, Wollert KC, Januzzi JL, Wang TJ, Tofler G, Vasan RS. Ideal cardiovascular health: associations with biomarkers and subclinical disease and impact on incidence of cardiovascular disease in the Framingham Offspring Study. Circulation. 2014; 130: 1676-1683. doi: 10.1161/CIRCULATIONAHA.114.009273.
25. Bluemke DA, Kronmal RA, Lima JA, Liu K, Olson J, Burke GL, Folsom AR. The relationship of left ventricular mass and geometry to incident cardiovascular events: the MESA (Multi-Ethnic Study of Atherosclerosis) study. J Am Coll Cardiol. 2008; 52: 2148-2155. doi: 10.1016/j. jacc.2008.09.014.
26. Kane GC, Karon BL, Mahoney DW, Redfield MM, Roger VL, Burnett JC Jr, Jacobsen SJ, Rodeheffer RJ. Progression of left ventricular diastolic dysfunction and risk of heart failure. JAMA. 2011; 306: 856-863. doi: 10.1001/jama.2011.1201.
27. Choi EY, Rosen BD, Fernandes VR, Yan RT, Yoneyama K, Donekal S, Opdahl A, Almeida AL, Wu CO, Gomes AS, Bluemke DA, Lima JA. Prognostic value of myocardial circumferential strain for incident heart failure and cardiovascular events in asymptomatic individuals: the Multi-Ethnic Study of Atherosclerosis. Eur Heart J. 2013; 34: 2354-2361. doi: 10.1093/eurheartj/eht133.
28. Zakeri R, Chamberlain AM, Roger VL, Redfield MM. Temporal relationship and prognostic significance of atrial fibrillation in heart failure patients with preserved ejection fraction: a community-based study. Circulation. 2013; 128: 1085-1093. doi: 10.1161/.CIRCULATIONAHA.113.001475.
29. Psaty BM, Manolio TA, Kuller LH, Kronmal RA, Cushman M, Fried LP, White R, Furberg CD, Rautaharju PM. Incidence of and risk factors for atrial fibrillation in older adults. Circulation. 1997; 96: 2455-2461.
30. Spring B, Moller AC, Colangelo LA, Siddique J, Roehrig M, Daviglus ML, Polak JF, Reis JP, Sidney S, Liu K. Healthy lifestyle change and subclinical atherosclerosis in young adults: Coronary Artery Risk Development in Young Adults (CARDIA) study. Circulation. 2014; 130: 10-17. doi: 10.1161/CIRCULATIONAHA.113.005445.
31. Hypertension Detection and Follow-up Program Cooperative Group. Five year findings of the hypertension detection and follow-up program: Reduction in mortality of persons with high blood pressure, including mild hypertension. JAMA. 1979; 242: 2562-71.
32. Hypertension Detection and Follow-up Program Cooperative Group. Five year findings of the hypertension detection and follow-up program: Reduction in stroke incidence among persons with high blood pressure. JAMA. 1982; 247: 633-8.
33. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, McKillop JH, Packard CJ. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med. 1995; 333: 1301-1307. doi: 10.1056/NEJM199511163332001.
34. Downs JR, Clearfield M, Weis S, Whitney E, Shapiro DR, Beere PA, Langendorfer A, Stein EA, Kruyer W, Gotto AM Jr. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA. 1998; 279: 1615-1622.